drugset / Trial / NCT02066727

Lidocaine Combined Dexmedetomidine for Obturator Nerve Block

NCT02066727 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

Hypothesis: Dexmedetomidine as an adjuvant of lidocaine can decrease the median effective concentration(EC50) of lidocaine for obturator nerve block during transurethral resection of bladder tumor

Timeline

Start
2014-02
Primary completion
2014-04
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 1 ug/kg Other